Determinants of the Pathological Features of Renal Adverse Effects Due to Vascular Endothelial Growth Factor Signaling Inhibition.
作者信息
Mori Kiyoshi
机构信息
Graduate School of Public Health, Shizuoka Graduate University of Public Health, Japan.
Department of Nephrology and Kidney Research, Shizuoka General Hospital, Japan.
出版信息
Intern Med. 2022 Dec 1;61(23):3469-3471. doi: 10.2169/internalmedicine.0044-22. Epub 2022 May 14.
Abstract
摘要
相似文献
1
Determinants of the Pathological Features of Renal Adverse Effects Due to Vascular Endothelial Growth Factor Signaling Inhibition.血管内皮生长因子信号抑制所致肾脏不良反应病理特征的决定因素
Intern Med. 2022 Dec 1;61(23):3469-3471. doi: 10.2169/internalmedicine.0044-22. Epub 2022 May 14.
2
Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney.塌陷性肾小球病在原发性肾脏血栓性微血管病中较为常见。
Kidney Int. 2016 Dec;90(6):1321-1331. doi: 10.1016/j.kint.2016.07.021. Epub 2016 Sep 17.
3
Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer.由于雷莫芦单抗治疗转移性乙状结肠癌导致的伴细胞新月体样形成的肾小球微血管病和血管内皮病。
Intern Med. 2022 Dec 1;61(23):3547-3552. doi: 10.2169/internalmedicine.9185-21. Epub 2022 May 14.
4
Collapsing glomerulopathy: clinical characteristics and follow-up.塌陷性肾小球病：临床特征与随访
Am J Kidney Dis. 1999 Apr;33(4):652-7. doi: 10.1016/s0272-6386(99)70215-5.
5
Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center.与抗血管内皮生长因子（VEGF）相关的肾脏疾病：单中心8年观察性研究
Medicine (Baltimore). 2014 Nov;93(24):333-339. doi: 10.1097/MD.0000000000000207.
6
Proteinuria in rats induced by serum from patients with collapsing glomerulopathy.塌陷型肾小球病患者血清诱导的大鼠蛋白尿
Kidney Int. 2004 Jul;66(1):133-43. doi: 10.1111/j.1523-1755.2004.00715.x.
7
Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes.肾移植中肾小球塌陷的区域分布：血管变化的可能作用。
Hum Pathol. 2002 Apr;33(4):437-41. doi: 10.1053/hupa.2002.124333.
8
HIV-associated nephropathy: experimental models.人类免疫缺陷病毒相关性肾病：实验模型
Contrib Nephrol. 2011;169:270-285. doi: 10.1159/000320212. Epub 2011 Jan 20.
9
Collapsing glomerulopathy: a clinically and pathologically distinct variant of focal segmental glomerulosclerosis.塌陷性肾小球病：一种临床和病理上独特的局灶节段性肾小球硬化变体。
Kidney Int. 1994 May;45(5):1416-24. doi: 10.1038/ki.1994.185.
10
Role of progenitor cell marker CD133 in supporting diagnosis of collapsing glomerulopathy.祖细胞标志物CD133在辅助诊断塌陷性肾小球病中的作用。
Int Urol Nephrol. 2022 Aug;54(8):1957-1968. doi: 10.1007/s11255-021-03078-0. Epub 2022 Jan 3.
本文引用的文献
1
Glomerular Microangiopathy with Cellular Crescent-like Formation and Endotheliopathy Due to Ramucirumab Treatment for Metastatic Sigmoid Colon Cancer.由于雷莫芦单抗治疗转移性乙状结肠癌导致的伴细胞新月体样形成的肾小球微血管病和血管内皮病。
Intern Med. 2022 Dec 1;61(23):3547-3552. doi: 10.2169/internalmedicine.9185-21. Epub 2022 May 14.
2
VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.VEGF-VEGFR2 抑制剂相关透明血栓性肾小球微血管病：日本单中心经验。
Clin Exp Nephrol. 2021 Nov;25(11):1193-1202. doi: 10.1007/s10157-021-02090-z. Epub 2021 Jun 11.
3
A case of ramucirumab-induced renal failure with nephrotic-range proteinuria and its pathological findings.一例雷莫芦单抗致肾衰竭伴大量蛋白尿及其病理表现。
BMJ Case Rep. 2021 Mar 2;14(3):e239603. doi: 10.1136/bcr-2020-239603.
4
Renal-limited thrombotic microangiopathy after switching from bevacizumab to ramucirumab: a case report.贝伐珠单抗转换为雷莫芦单抗后致肾局限性血栓性微血管病：1 例报告
BMC Nephrol. 2019 Jan 11;20(1):14. doi: 10.1186/s12882-018-1194-9.
5
Bevacizumab-associated glomerular microangiopathy.贝伐珠单抗相关性肾小球微血管病。
Mod Pathol. 2019 May;32(5):684-700. doi: 10.1038/s41379-018-0186-4. Epub 2018 Dec 14.
6
Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.抗血管内皮生长因子治疗引起的肾小球微血管病变的特征性形态学改变。
Histopathology. 2018 Dec;73(6):990-1001. doi: 10.1111/his.13716. Epub 2018 Sep 25.
7
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance.VEGF-C 在贝伐珠单抗治疗下维持 VEGFR2 激活，并促进胶质母细胞瘤的维持。
Neuro Oncol. 2018 Oct 9;20(11):1462-1474. doi: 10.1093/neuonc/noy103.
8
Meta-analysis of individual patient safety data from six randomized, placebo-controlled trials with the antiangiogenic VEGFR2-binding monoclonal antibody ramucirumab.来自六项抗血管生成 VEGFR2 结合单克隆抗体 ramucirumab 的随机、安慰剂对照试验的个体患者安全性数据的荟萃分析。
Ann Oncol. 2017 Dec 1;28(12):2932-2942. doi: 10.1093/annonc/mdx514.
9
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.非典型溶血尿毒综合征与 C3 肾小球病：“改善全球肾脏病预后组织”（KDIGO）争议会议的结论。
Kidney Int. 2017 Mar;91(3):539-551. doi: 10.1016/j.kint.2016.10.005. Epub 2016 Dec 16.
10
Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney.塌陷性肾小球病在原发性肾脏血栓性微血管病中较为常见。
Kidney Int. 2016 Dec;90(6):1321-1331. doi: 10.1016/j.kint.2016.07.021. Epub 2016 Sep 17.
Zotero 插件